Table 3_Is full adherence mandatory? Real-world outcomes of completing perioperative chemo

A clinical study dataset of 164 patients with resectable non-small cell lung cancer (stages IB-IIIB) who received neoadjuvant chemoimmunotherapy followed by surgery. The data compares recurrence-free survival, overall survival, and adverse events between patients who completed the full perioperative regimen (n=37) and those who did not (n=127). The dataset was authored by Zhoujunyi Tian and last updated on 2026-05-28.

Use Cases

• Compare recurrence-free survival between treatment adherence groups based on the Kaplan-Meier analysis described.
• Assess predictors of cancer recurrence based on factors like pathological nodal status mentioned in the results.
• Analyze the incidence of adverse events associated with completing the full treatment regimen.
• Conduct subgroup analyses to identify patient populations (e.g., age <65, ECOG score 0) that may benefit from treatment completion.

Strengths

• Includes data for 164 patients with resectable non-small cell lung cancer.
• Uses Inverse Probability of Treatment Weighting to adjust for baseline characteristics, a method mentioned in the description.
• Reports specific statistical results, including hazard ratios and p-values for survival comparisons.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The dataset is very small at 17.6 KB, indicating limited scope.

Provenance

Source

figshare

Collection Method

Clinical study of patients who received neoadjuvant chemoimmunotherapy followed by surgery.

Freshness

Last updated 2026-05-28 04:45:41; freshness should be verified.